Patents by Inventor Sudarshan Hebbar

Sudarshan Hebbar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING ACUTE KIDNEY INJURY
    Publication number: 20230226058
    Abstract: Compositions and methods related to the treatment of acute kidney injury (AKI) through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to reduce inflammatory responses that may lead to AKI, or the progression of AKI to CKD.
    Type: Application
    Filed: November 18, 2022
    Publication date: July 20, 2023
    Inventors: Kenneth A. STAUDERMAN, Michael DUNN, Sudarshan HEBBAR, Rachel LEHENY
  • METHODS AND COMPOSITIONS FOR TREATING ACUTE LUNG INJURY AND ACUTE RESPIRATORY DISTRESS SYNDROME
    Publication number: 20230120819
    Abstract: Compositions and methods related to the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) including viral pneumonia through the pharmaceutical manipulation of calcium signaling are disclosed. Such compositions and methods may be used to reduce pro-inflammatory cytokine releases that may lead to ALI and/or ARDS.
    Type: Application
    Filed: March 19, 2021
    Publication date: April 20, 2023
    Inventors: Kenneth A. STAUDERMAN, Michael DUNN, Sudarshan HEBBAR, Rachel LEHENY
  • CRAC CHANNEL INHIBITORS FOR THE TREATMENT OF STROKE AND TRAUMATIC BRAIN INJURY
    Publication number: 20200101069
    Abstract: Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.
    Type: Application
    Filed: August 8, 2019
    Publication date: April 2, 2020
    Inventors: Kenneth STAUDERMAN, Michael DUNN, Sudarshan HEBBAR, Midori YENARI, Rachid KACIMI
  • Use of CRAC channel inhibitors for the treatment of stroke and traumatic brain injury
    Patent number: 10478435
    Abstract: Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: November 19, 2019
    Assignees: CALCIMEDICA, INC., THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Kenneth Stauderman, Michael Dunn, Sudarshan Hebbar, Midori Yenari, Rachid Kacimi
  • Use of CRAC channel inhibitors for the treatment of stroke and traumatic brain injury
    Patent number: 10420766
    Abstract: Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: September 24, 2019
    Assignees: CALCIMEDICA, INC., THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Kenneth Stauderman, Michael Dunn, Sudarshan Hebbar, Midori Yenari, Rachid Kacimi
  • USE OF CRAC CHANNEL INHIBITORS FOR THE TREATMENT OF STROKE AND TRAUMATIC BRAIN INJURY
    Publication number: 20180235959
    Abstract: Described herein are methods of treatment of stroke and traumatic brain injury comprising administration of a CRAC channel inhibitor.
    Type: Application
    Filed: August 5, 2016
    Publication date: August 23, 2018
    Inventors: Kenneth STAUDERMAN, Michael DUNN, Sudarshan HEBBAR, Midori YENARI, Rachid KACIMI
  • Method and system for managing patient healthcare
    Patent number: 8930222
    Abstract: Methods and systems are provided for managing patient healthcare, which include creating a patient profile for a patient, screening and assessing the patient with respect to a disease and updating the patient profile, determining a health management status of the patient with respect to the disease based on a comparison of the updated patient profile to at least one predefined criterion regarding progression of the disease, and providing a recommended action based upon the health management status and updated patient profile.
    Type: Grant
    Filed: August 5, 2011
    Date of Patent: January 6, 2015
    Assignee: Abbott Laboratories
    Inventors: Amy L. Rhine-Pallas, Robert J. Padley, Brett M. Hickman, Clifford Bleustein, Refaat A. Hegazi, Sudarshan Hebbar, David K. Spindell, Paul Audhya
  • Biomarkers for prediction of major adverse cardiac events and uses thereof
    Patent number: 8658384
    Abstract: The present invention relates to combinations of biomarkers and levels thereof that may be used, for example, in the determination of risk associated with the occurrence of a major adverse cardiac event (MACE) in a patient.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: February 25, 2014
    Assignee: Abbott Laboratories
    Inventors: Saul A. Datwyler, Jessie W. Shih, Robert C. Doss, Walter J. Keirans, Sudarshan Hebbar
  • Biomarkers For Prediction Of Major Adverse Cardiac Events And Uses Thereof
    Publication number: 20130288269
    Abstract: The present invention relates to combinations of biomarkers and levels thereof that may be used, for example, in the determination of risk associated with the occurrence of a major adverse cardiac event (MACE) in a patient.
    Type: Application
    Filed: June 25, 2013
    Publication date: October 31, 2013
    Applicant: ABBOTT LABORATORIES
    Inventors: Saul A. Datwyler, Jessie W. Shih, Robert C. Doss, Walter J. Keirans, Sudarshan Hebbar
  • Biomarkers for prediction of major adverse cardiac events and uses thereof
    Patent number: 8501420
    Abstract: The present invention relates to combinations of biomarkers and levels thereof that may be used, for example, in the determination of risk associated with the occurrence of a major adverse cardiac event (MACE) in a patient.
    Type: Grant
    Filed: August 30, 2010
    Date of Patent: August 6, 2013
    Assignee: Abbott Laboratories
    Inventors: Saul A. Datwyler, Jessie W. Shih, Robert C. Doss, Walter J. Keirans, Sudarshan Hebbar
  • Method And System For Managing Patient Healthcare
    Publication number: 20120035958
    Abstract: Methods and systems are provided for managing patient healthcare, which include creating a patient profile for a patient, screening and assessing the patient with respect to a disease and updating the patient profile, determining a health management status of the patient with respect to the disease based on a comparison of the updated patient profile to at least one predefined criterion regarding progression of the disease, and providing a recommended action based upon the health management status and updated patient profile.
    Type: Application
    Filed: August 5, 2011
    Publication date: February 9, 2012
    Inventors: Amy L. Rhine-Pallas, Robert J. Padley, Brett M. Hickman, Clifford Bleustein, Refaat A. Hegazi, Sudarshan Hebbar, David K. Spindell, Paul Audhya
  • METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
    Publication number: 20110229921
    Abstract: A method of prognosticating cadaveric kidney transplant function in a patient; a method of prognosticating cadaveric kidney transplant function in a patient diagnosed with DGF; a method of assessing risk of DGF in a patient, who has been diagnosed with EGF; and a kit comprising at least one component for assaying urine from a patient for NGAL and instructions for assaying the urine for NGAL and assessing cadaveric kidney transplant function or risk of DGF in the patient.
    Type: Application
    Filed: June 9, 2010
    Publication date: September 22, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Robert C. Doss, Sudarshan Hebbar
  • Biomarkers For Prediction Of Major Adverse Cardiac Events And Uses Thereof
    Publication number: 20110053179
    Abstract: The present invention relates to combinations of biomarkers and levels thereof that may be used, for example, in the determination of risk associated with the occurrence of a major adverse cardiac event (MACE) in a patient.
    Type: Application
    Filed: August 30, 2010
    Publication date: March 3, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Saul A. Datwyler, Jessie W. Shih, Robert C. Doss, Walter J. Keirans, Sudarshan Hebbar